Annual Accounts Payable
$2.59 M
-$217.33 K-7.75%
December 31, 2023
Summary
- As of March 6, 2025, SBFMW annual accounts payable is $2.59 million, with the most recent change of -$217.33 thousand (-7.75%) on December 31, 2023.
- During the last 3 years, SBFMW annual accounts payable has risen by +$2.52 million (+4012.40%).
- SBFMW annual accounts payable is now -7.75% below its all-time high of $2.80 million, reached on December 31, 2022.
Performance
SBFMW Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.16 M
-$772.80 K-15.68%
September 30, 2024
Summary
- As of March 6, 2025, SBFMW quarterly accounts payable is $4.16 million, with the most recent change of -$772.80 thousand (-15.68%) on September 30, 2024.
- Over the past year, SBFMW quarterly accounts payable has stayed the same.
- SBFMW quarterly accounts payable is now -15.68% below its all-time high of $4.93 million, reached on June 30, 2024.
Performance
SBFMW Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SBFMW Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.8% | 0.0% |
| 3 y3 years | +4012.4% | +4265.3% |
| 5 y5 years | +1253.1% | +6512.5% |
SBFMW Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.8% | +5920.8% | -15.7% | +9581.1% |
| 5 y | 5-year | -7.8% | +5920.8% | -15.7% | +9581.1% |
| alltime | all time | -7.8% | >+9999.0% | -15.7% | -100.0% |
Sunshine Biopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.16 M(-15.7%) |
| Jun 2024 | - | $4.93 M(+36.4%) |
| Mar 2024 | - | $3.62 M(+39.8%) |
| Dec 2023 | $2.59 M(-7.8%) | $2.59 M(+16.4%) |
| Sep 2023 | - | $2.22 M(+26.2%) |
| Jun 2023 | - | $1.76 M(-35.7%) |
| Mar 2023 | - | $2.74 M(-2.4%) |
| Dec 2022 | $2.80 M(+6426.9%) | $2.80 M(+483.7%) |
| Sep 2022 | - | $480.21 K(+358.7%) |
| Jun 2022 | - | $104.68 K(+9.9%) |
| Mar 2022 | - | $95.23 K(+121.8%) |
| Dec 2021 | $42.94 K(-31.7%) | $42.94 K(-24.2%) |
| Sep 2021 | - | $56.69 K(-45.1%) |
| Jun 2021 | - | $103.19 K(-30.5%) |
| Mar 2021 | - | $148.56 K(+136.3%) |
| Dec 2020 | $62.87 K(-35.1%) | $62.87 K(+9.0%) |
| Sep 2020 | - | $57.69 K(-35.8%) |
| Jun 2020 | - | $89.88 K(-8.2%) |
| Mar 2020 | - | $97.96 K(+1.1%) |
| Dec 2019 | $96.88 K(-49.3%) | $96.88 K(+49.4%) |
| Sep 2019 | - | $64.83 K(-23.2%) |
| Jun 2019 | - | $84.38 K(-39.9%) |
| Mar 2019 | - | $140.34 K(-26.6%) |
| Dec 2018 | $191.08 K(+889.3%) | $191.08 K(+82.0%) |
| Sep 2018 | - | $104.99 K(-24.5%) |
| Jun 2018 | - | $139.02 K(+22.6%) |
| Mar 2018 | - | $113.36 K(+486.9%) |
| Dec 2017 | $19.31 K(-31.3%) | $19.31 K(+59.6%) |
| Sep 2017 | - | $12.11 K(-65.1%) |
| Jun 2017 | - | $34.71 K(+24.2%) |
| Mar 2017 | - | $27.95 K(-0.6%) |
| Dec 2016 | $28.12 K(-39.6%) | $28.12 K(+45.9%) |
| Sep 2016 | - | $19.28 K(-46.0%) |
| Jun 2016 | - | $35.71 K(+45.9%) |
| Mar 2016 | - | $24.48 K(-47.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $46.59 K(+34.0%) | $46.59 K(+34.5%) |
| Sep 2015 | - | $34.64 K(-2.9%) |
| Jun 2015 | - | $35.67 K(-23.5%) |
| Mar 2015 | - | $46.60 K(+34.0%) |
| Dec 2014 | $34.77 K(+46.0%) | $34.77 K(-32.3%) |
| Sep 2014 | - | $51.32 K(-45.3%) |
| Jun 2014 | - | $93.87 K(+89.6%) |
| Mar 2014 | - | $49.51 K(+108.0%) |
| Dec 2013 | $23.81 K(+3901.5%) | $23.81 K(+171.7%) |
| Sep 2013 | - | $8763.00(+2890.8%) |
| Jun 2013 | - | $293.00(-96.5%) |
| Mar 2013 | - | $8338.00(+1301.3%) |
| Dec 2012 | $595.00(-82.7%) | $595.00(-62.6%) |
| Sep 2012 | - | $1590.00(-90.4%) |
| Jun 2012 | - | $16.50 K(+106.2%) |
| Mar 2012 | - | $8002.00(+133.0%) |
| Dec 2011 | $3434.00(-69.9%) | $3434.00(-24.4%) |
| Sep 2011 | - | $4545.00(>+9900.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $330.00(-97.1%) |
| Dec 2010 | $11.40 K(-20.3%) | $11.40 K(-52.0%) |
| Sep 2010 | - | $23.78 K(+42.4%) |
| Jun 2010 | - | $16.70 K(+4.4%) |
| Mar 2010 | - | $15.99 K(>+9900.0%) |
| Dec 2009 | $14.31 K(+174.6%) | - |
| Oct 2009 | - | $0.00(-100.0%) |
| Jul 2009 | - | $9972.00(+58.8%) |
| Apr 2009 | - | $6280.00(+6.4%) |
| Jan 2009 | - | $5905.00(+59.0%) |
| Oct 2008 | - | $3713.00(-28.8%) |
| Jul 2008 | $5213.00(+247.5%) | $5213.00(+39.7%) |
| Apr 2008 | - | $3732.00(+47.0%) |
| Jan 2008 | - | $2538.00(-22.8%) |
| Oct 2007 | - | $3288.00 |
| Jul 2007 | $1500.00 | - |
FAQ
- What is Sunshine Biopharma annual accounts payable?
- What is the all time high annual accounts payable for Sunshine Biopharma?
- What is Sunshine Biopharma annual accounts payable year-on-year change?
- What is Sunshine Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly accounts payable year-on-year change?
What is Sunshine Biopharma annual accounts payable?
The current annual accounts payable of SBFMW is $2.59 M
What is the all time high annual accounts payable for Sunshine Biopharma?
Sunshine Biopharma all-time high annual accounts payable is $2.80 M
What is Sunshine Biopharma annual accounts payable year-on-year change?
Over the past year, SBFMW annual accounts payable has changed by -$217.33 K (-7.75%)
What is Sunshine Biopharma quarterly accounts payable?
The current quarterly accounts payable of SBFMW is $4.16 M
What is the all time high quarterly accounts payable for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly accounts payable is $4.93 M
What is Sunshine Biopharma quarterly accounts payable year-on-year change?
Over the past year, SBFMW quarterly accounts payable has changed by $0.00 (0.00%)